May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive... Read More
category
companyNews
6 Healthy Products That Aren't
May 20, 2013
Investors in Pfizer Inc (PFE) saw new options become available today, for the March 2014 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value,... Read More
category
Stocks
from Market News Video
Noteworthy ETF Inflows: VTV, GE, PFE, T
May 20, 2013
Symbols mentioned in this story: VTV, GE, PFE, T Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can... Read More
category
ETFs
from ETF Channel
In 2011, the world’s two largest drugmakers – Pfizer and Merck – each announced major China drug JVs with domestic China pharmas – Hisun in Pfizer’s case and Simcere for Merck. The arrangements were... Read More
from ChinaBio® Today
category
Pharmaceuticals
,
Medical Devices & Supplies
from Trefis
On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), in their attempts to accelerate the discovery and development of... Read More
category
NASDAQ:VRTX
,
NYSE:PFE
from Forbes Real Time
category
companyNews
Zoetis (ZTS) Reveise FDA Approval of APOQUEL
May 16, 2013
from AVAFIN
Finding the Next Big Blockbuster Drug
May 15, 2013
from ACCESSWIRE
New cancer tools allow patients to reconsider chemo
May 15, 2013
LOS ANGELES, May 15 (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh... Read More
category
companyNews
StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX
May 15, 2013
from ACCESSWIRE
from Business Journals
Should I Buy Pfizer? 3 Pros, 3 Cons
May 15, 2013
Natural Products Ingredient Innovator Generating Interest Among Investors Institutions and Industry
May 14, 2013
from ACCESSWIRE
Final Trade: Your First Move for Wednesday, May 15
May 14, 2013
from CNBC.com News
XLV, UWM: Big ETF Outflows
May 14, 2013
Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the Health Care Select Sector SPDR Fund (XLV), which shed... Read More
category
ETFs
from ETF Channel
category
Pharmaceuticals
from Trefis
from Business Journals
New Data On Boston Scientific’s Atrial Fibrillation ‘Watchman’ Device Could Lift Outlook
May 13, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from Trefis
category
Pharmaceuticals
from Trefis
Pfizer - Daily Volume Review
May 13, 2013
from AVAFIN
category
Pharmaceuticals
from Trefis
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
NEW YORK, May 10 (Reuters) - The Dow and S&P 500 ended at record highs on Friday, and stocks posted a third consecutive week of gains as a rise in Google and other technology shares offset a slide in... Read More
category
companyNews
from Business Journals
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here